
MHE October 2023



Laws since 1996 have sought to assure that coverage of behavioral health treatments does not take a back seat to physical medicine. Amid a national crisis in mental illness and addiction, that new world of equality has not arrived. But is it on the way?

Two drugs that target the c-MET protein are in phase 3 trials.

Payers and hospitals are at odds over proposals that would level out payments to hospital outpatient departments and physician offices.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
500,000 Medicaid beneficiaries with diabetes to lose coverage by 2034
2
Ashley Holzworth-Nash, Pharm.D., Evernorth
3
Does Medicare’s drug price negotiation disincentivize biosimilar development?
4
Adalimumab grabs top spot as most cost-efficient biologic for hidradenitis suppurativa
5


